Last February, Richard Pollock was reading a review in the Cochrane Database of Systematic Reviews — a prominent resource for evidence-based medicine — when he spotted an error.
In the first figure, which compared the effectiveness of two different treatments for the most common form of liver cancer, a label was switched. The error made it seem like the “worse” treatment was better than the more effective option.
Pollock, a health economist, was concerned enough to send an email to Omar Abdel-Rahman, the corresponding author, on February 20th. Abdel-Rahman, an oncologist at the University of Alberta, wrote back the next day, saying he would review the comments with experts at Cochrane, “and if there is any typos in the publication, it will be corrected immediately.” Emails seen by Retraction Watch show that, when replying to this email, Abdel-Rahman copied one of Cochrane’s editors, Dimitrinka Nikolova.
Months passed. Pollock sent another email to Abdel-Rahman and two Cochrane editors — Nikolova and Christian Gluud — on June 15th. Then, on November 16th, the journal pulled the review with a brief notice:
Continue reading Leading evidence-based group blames pandemic for 9-month delay pulling flawed cancer review